Moonlake Immunotherapeutics (MLTX) — SC 13D/A Filings
All SC 13D/A filings from Moonlake Immunotherapeutics. Browse 2 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (2)
-
BVF Partners L.P. Amends MoonLake Immunotherapeutics Stake
— Oct 8, 2024 Risk: medium
BVF Partners L.P. has amended its Schedule 13D filing regarding MoonLake Immunotherapeutics, as of October 8, 2024. The filing indicates a change in beneficial -
BVF Partners L.P. Ups Stake in MoonLake Immunotherapeutics
— Mar 5, 2024 Risk: medium
BVF Partners L.P. has amended its Schedule 13D filing regarding MoonLake Immunotherapeutics, reporting a beneficial ownership of 10,000,000 shares of Class A Or
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX